Enzyme replacement therapy in the mouse model of Pompe disease
- 26 September 2003
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 80 (1-2) , 159-169
- https://doi.org/10.1016/j.ymgme.2003.08.022
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Enzyme replacement and enhancement therapies: lessons from lysosomal disordersNature Reviews Genetics, 2002
- Enzyme therapy for Pompe disease: from science to industrial enterpriseEuropean Journal of Pediatrics, 2002
- Enzyme replacement therapy for the mucopolysaccharide storage disordersExpert Opinion on Investigational Drugs, 2002
- Acid a-Glucosidase Deficiency (Glycogenosis Type II, Pompe Disease)Current Molecular Medicine, 2002
- Identification of two subtypes of infantile acid maltase deficiencyThe Journal of Pediatrics, 2000
- Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant SourcesAnnals of Internal Medicine, 1995
- STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORSAnnual Review of Biochemistry, 1992
- LYSOSOMAL STORAGE DISEASESAnnual Review of Biochemistry, 1991
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)Biochemical Journal, 1963